The consumption of fructose from fruit juice and sugar sweetened beverages (SSBs), but not from fruit, is associated with higher intrahepatic lipid (IHL) content, according to data from a cross-sectional study presented at EASD 2021.
Older age and elevated levels of the inflammatory marker C-reactive protein (CRP) may predict mortality in COVID-19 patients, particularly if coupled with diabetes, the retrospective ACCREDIT study has shown.
A novel fully closed-loop system (fully artificial pancreas) delivering faster-acting insulin aspart (Fiasp) plus pramlintide achieved a high rate of glycaemic control among patients with type 1 diabetes (T1D) without the need for carbohydrate counting, according to a crossover noninferiority study presented at EASD 2021.
Individuals who are obese but without metabolic abnormalities (metabolically healthy obese [MHO]) have an elevated risk of developing MACE-HF*, new-onset heart failure (HF), and new-onset atrial fibrillation (AF), according to a French study presented at EASD 2021.
In individuals with type 2 diabetes (T2D), the glucagon-like peptide-1 receptor agonist (GLP1-RA) liraglutide appeared to yield a cardioprotective benefit, data from the secondary endpoint analysis of the LIRAFLAME* trial suggests.
While people with type 2 diabetes (T2D) have an increased risk of developing dementia, this excess risk can be mitigated by maintaining a healthy lifestyle to keep several risk factors under control, according to a study presented at EASD 2021.